Innate Pharma SA (IPHA)
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.
Address
117 AVENUE DE LUMINY
MARSEILLE, I0 13009
Founded
1999
Number of Employees
179
Website
http://www.innate-pharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)